Article Information
History
- September 18, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Shamil Haroon, PhD*,1,
- Anuradhaa Subramanian, MSc*,1,
- Jennifer Cooper, MBBCh1,
- Astha Anand, BMBCh1,
- Krishna Gokhale, MSc1,
- Nathan Byne2,
- Samir Dhalla, MRPharmS3,
- Dionisio Acosta-Mena, PhD2,
- Thomas Taverner, PhD1,
- Kelvin Okoth, MPH1,
- Jingya Wang, PhD1,
- Joht Singh Chandan, PhD1,
- Christopher Sainsbury, MD1,4,
- Dawit Tefra Zemedikun, PhD1,
- G. Neil Thomas, PhD1,
- Dhruv Parekh, PhD5,
- Tom Marshall, PhD1,
- Elizabeth Sapey, PhD5,6,
- Nicola J Adderley, PhD1,# and
- Krishnarajah Nirantharakumar, MD1,7,8
- 1Institute of Applied Health Research, University of Birmingham, Birmingham, UK
- 2Cegedim Health Data, Cegedim Rx, London, UK
- 3The Health Improvement Network (THIN), London, UK
- 4Department of Diabetes, Gartnavel General Hospital, NHS Greater Glasgow and Clyde, UK
- 5Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK; Department of Acute Medicine, Queen Elizabeth Hospital Birmingham, UK
- 6PIONEER, The Health Data Research UK Hub in acute care
- 7Department of Diabetes and Endocrinology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
- 8Midlands Health Data Research UK, Birmingham, UK
- ↵#Corresponding authors: Nicola J Adderley (N.J.Adderley{at}bham.ac.uk)
↵* Contributed equally to the manuscript
Posted September 18, 2020.
Renin-angiotensin system inhibitors and susceptibility to COVID-19 in patients with hypertension: a propensity score-matched cohort study in primary care
